TY - JOUR
T1 - Development and characterization of rifampicin loaded floating microspheres
AU - Goyal, Pankaj
AU - Gill, S.
AU - Gupta, U. D.
AU - Rath, Goutam
AU - Narang, Raj K.
AU - Goyal, Amit K.
N1 - Generated from Scopus record by KAUST IRTS on 2023-10-12
PY - 2011/10/1
Y1 - 2011/10/1
N2 - Gastroretentive floating microspheres have a potential for enhancing the bioavailability and controlled delivery of drugs. The present study involves development of rifampicin floating microspheres in order to increase the gastric retention time. The microspheres were prepared by solvent evaporation technique and characterized for particle size, shape, zeta-potential, entrapment, and release kinetics. The developed systems were almost spherical in shape. The entrapment efficiency was found to be 86.34%. The percentage buoyancy after 8 hours was found to be 61.06. The prepared microspheres exhibited prolonged drug release in gastric medium and hence could be utilized for sustained delivery of anti-tubercular drugs. © 2011 Informa Healthcare USA, Inc.
AB - Gastroretentive floating microspheres have a potential for enhancing the bioavailability and controlled delivery of drugs. The present study involves development of rifampicin floating microspheres in order to increase the gastric retention time. The microspheres were prepared by solvent evaporation technique and characterized for particle size, shape, zeta-potential, entrapment, and release kinetics. The developed systems were almost spherical in shape. The entrapment efficiency was found to be 86.34%. The percentage buoyancy after 8 hours was found to be 61.06. The prepared microspheres exhibited prolonged drug release in gastric medium and hence could be utilized for sustained delivery of anti-tubercular drugs. © 2011 Informa Healthcare USA, Inc.
UR - http://www.tandfonline.com/doi/full/10.3109/10731199.2011.573482
UR - http://www.scopus.com/inward/record.url?scp=80052721768&partnerID=8YFLogxK
U2 - 10.3109/10731199.2011.573482
DO - 10.3109/10731199.2011.573482
M3 - Article
SN - 1073-1199
VL - 39
SP - 330
EP - 334
JO - Artificial Cells, Blood Substitutes, and Biotechnology
JF - Artificial Cells, Blood Substitutes, and Biotechnology
IS - 5
ER -